| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ia/ Managing Member Of 10% Owne | Ia/ Managing Member 10% Owner
1 company
Epiq Capital Group, LLC is an Ia/ Managing Member Of 10% Owne at Quince Therapeutics, Inc.. Recent SEC Form 4 filings include 15 buys and 0 sells.
Estimated insider holdings value: $2.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 12, 2020 | QNCX Quince Therapeutics, Inc. | Ia/ Managing Member Of 10% Owne | Buy | 9,040 | $44.25 | $400,018.40 | +0.2% | |
| May 22, 2020 | QNCX Quince Therapeutics, Inc. | Ia/ Managing Member Of 10% Owne | Buy | 8,690 | $57.33 | $498,172.24 | - | |
| Aug 21, 2019 | QNCX Quince Therapeutics, Inc. | Ia/ Managing Member 10% Owner | Buy | 4,965 | $25.35 | $125,862.67 | - | |
| Aug 19, 2019 | QNCX Quince Therapeutics, Inc. | Ia/ Managing Member 10% Owner | Buy | 2,800 | $26.46 | $74,099.90 | - | |
| May 10, 2019 | QNCX Quince Therapeutics, Inc. | Ia/ Managing Member 10% Owner | Buy | 8,600 | $26.98 | $232,056.10 | +0.1% |